Inventor
MESENS JEAN
BE12 patents
⚠️ This page may combine multiple inventors who share the name “MESENS JEAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALKERMES INC
6 patentsUS5792477AAug 11, 1998
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
ALKERMES INC247 citations99
US6544559B2Apr 8, 2003
Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
ALKERMES INC76 citations98
US5965168AOct 12, 1999
Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
ALKERMES INC128 citations98
US5770231AJun 23, 1998
Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles 1,2-benzisothiazoles
ALKERMES INC182 citations98
US6110921AAug 29, 2000
Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
ALKERMES INC44 citations96
US7547452B2Jun 16, 2009
Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
ALKERMES INC5 citations73
JANSSEN PHARMACEUTICA NV
5 patentsUS5688801ANov 18, 1997
Method of inhibiting neurotransmitter activity using microencapsulated 3-piperidiny2-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
JANSSEN PHARMACEUTICA NV150 citations98
US7118763B2Oct 10, 2006
Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
JANSSEN PHARMACEUTICA NV41 citations96
US6368632B1Apr 9, 2002
Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
JANSSEN PHARMACEUTICA NV34 citations96
US4289783ASep 15, 1981
Etomidate-containing compositions
JANSSEN PHARMACEUTICA NV13 citations73
US4213963AJul 22, 1980
Fluspirilene-containing compositions
JANSSEN PHARMACEUTICA NV4 citations54